Related Experiment Video
Updated: Aug 16, 2026
04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
[Phase II trial with cystemustine (60 mg/m2) in advanced or metastatic pretreated lung carcinoma]
P Rebattu1, B Coudert, M Schneider
1Centre Léon Berard, 28 rue Laennec, 69373 Lyon Cedex 08, France.
Revue De Pneumologie Clinique
|July 6, 2000
Abstract:
From January 1990 to November 1994, 23 patients with advanced pretreated lung carcinoma were enrolled into a phase II trial to test a new nitrosourea, cystemustine, given every 2 weeks at the dose of 60 mg/m(2) in a 15-minute IV infusion. All eligible patients were considered evaluable for response and toxicity (WHO criteria).
